Evidence map›Paper›PMID 41398836›Full record

ArticleMedicine2025

Lupus miliaris disseminatus faciei with madarosis: A novel presentation.

Yuanting Su, Wei Cui

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuanting SuDepartment of Dermatology, The Second People's Hospital of Hefei, Hefei, Anhui, China.ORCID 0000-0002-9902-3725
Wei Cui

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleLupus miliaris disseminatus faciei (LMDF) is a chronic, self-limiting inflammatory skin disease of unknown etiology that can lead to disfiguring scars. PATIENT CONCERNS: A 51-year-old male presented with a 1-month history of facial papules and eyebrow exfoliation. DIAGNOSES: Skin biopsy confirmed that this case was LMDF.

interventionsAfter the diagnosis was confirmed, the patient was treated with oral doxycycline (100 mg) and prednisone (12 mg) once daily. OUTCOMES: Follow-up at 1 month showed significant improvement in facial rash and regrowth of both eyebrows. LESSONS: This report describes an atypical case of LMDF complicated by eyebrow loss, providing insights into the rarity and pathogenesis of this condition.

Indexed as

Facial DermatosesRosaceaDoxycyclineEyebrowsHumansMaleMiddle AgedPrednisoneDoxycyclinePrednisonelupus miliaris disseminatus facieimadarosispathogenesisscar

Identifiers

PMID41398836
PMCPMC12708200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.